Comparison of allergen immunotherapy and drug treatment in seasonal rhinoconjunctivitis: A 3-years study

European Annals of Allergy and Clinical Immunology

Volumn 37, Issue 2, 2005, Pages 69-71

  Giovannini, M ^a   Braccioni, F ^a   Sella, G ^a   Contoli, M ^a   Perri, G ^a   Frati, F ^c   Incorvaia, C ^b  

^a Municipal Hospital of Lugo   (Italy)

^b ICP Hospital   (Italy)

^c Scientific Department Stallergenes   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CALCIUM PHOSPHATE; CETIRIZINE; LEVOCABASTINE; MOMETASONE FUROATE; PHOSTAL; POLLEN EXTRACT; STEROID;

ADULT; ALLERGIC CONJUNCTIVITIS; ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; IMMUNOTHERAPY; MALE; POLLEN ALLERGY; RHINOCONJUNCTIVITIS; SEASONAL ALLERGIC CONJUNCTIVITIS; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ADULT; ALLERGENS; ANTI-ALLERGIC AGENTS; ANTI-INFLAMMATORY AGENTS; CETIRIZINE; CONJUNCTIVITIS, ALLERGIC; DESENSITIZATION, IMMUNOLOGIC; DRUG THERAPY, COMBINATION; FEMALE; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; MALE; OPHTHALMIC SOLUTIONS; PIPERIDINES; POACEAE; POLLEN; PREGNADIENEDIOLS; RHINITIS, ALLERGIC, SEASONAL; TREATMENT OUTCOME;

EID: 15044352216     PISSN: 03979148     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Bousquet J, van Cauwenberge P. - Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108:S1-315.
2. Bousquet J., Lockey R.-F., Mailing H.-J. - WHO position paper. Allergen immunotherapy: therapeutic vaccines for allergic disease. Allergy 1998;53(S44):1-42.
3. Mosbech H., Osterballe O. - Does the effect of immunotherapy last after termination of the treatment? Follow-up study in patients with grass pollen rhinitis. Allergy 1988;43:523-9.
4. Naclerio R.-M., Proud D., Moylan B. and al. - A double-blind study of the discontinuation of ragweed immunotherapy. J Allergy Clin Immunol 1997;100:293-300.
5. Durham S.-R., Walker S.-M., Varga E.-M. and al. - Long-term clinical efficacy of grass pollen immunotherapy. N Engl J Med 1999;341:468-75.
6. Ortolani C., Pastorello E.-A., Moss R.-B. and al. - Grass pollen immunotherapy: a single year double-blind, placebo-controlled study in patients with grass-pollen induced asthma and rhinitis. J Allergy Clin Immunol 1984; 73:283-90.
7. Bousquet J., Hejjaoui A., Soussana M., Michel F.-B. - Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. IV. Comparison of the safety and efficacy of two dosages of high-molecular-weight allergoid. J Allergy Clin Immunol 1990;85:490-7.
8. Pastorello E.-A., Pravettoni V., Incorvaia C. and al. - Clinical and immunological effects of immunotherapy with alum-absorbed grass allergoid in grass-pollen induced hay fever. Allergy 1992;47:281-90.
9. Juniper E.-F., Kline P.-A., Ramsdale E.-H., Hargreave F.-E. - Comparison of the efficacy and side effects of aqueous steroid nasal spray (budesonide) and allergen-injection immunotherapy (Pollinex-R) in the treatment of seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 1990;85:606-11.
10. Varney V.-A., Gaga M., Frew A. and al. - Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. BMJ 1991;302:265-9.
11. Pajno G.-B., Vita D., Parmiani S. and al. - Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with inhaled fluticasone propionate. Clin Exp Allergy 2003;33:1641-47.
12. Leynadier F., Banoun L., Dollois B. and al. - Immunotherapy with a calcium phosphate-adsorbed five-grass-pollen extract in seasonal rhinoconjunctivitis: a double-blind, placebo-controlled study. Clin Exp Allergy 2001;31:988-96.
13. Moller C., Dreborg S., Ferdousi H.-A. and al. - Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 2002;109:251-6.